Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring
Abstract COVID-19 is an infection induced by the SARS-CoV-2 coronavirus, and severe forms can lead to acute respiratory distress syndrome (ARDS) requiring intensive care unit (ICU) management. Severe forms are associated with coagulation changes, mainly characterized by an increase in D-dimer and fi...
Main Authors: | Sophie Susen, Charles Ambroise Tacquard, Alexandre Godon, Alexandre Mansour, Delphine Garrigue, Philippe Nguyen, Anne Godier, Sophie Testa, Jerrold H. Levy, Pierre Albaladejo, Yves Gruel, on behalf of GIHP and GFHT |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13054-020-03000-7 |
Similar Items
-
Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin
by: Chantal Visser, et al.
Published: (2020-12-01) -
Timing of Heparin Administration Modulates Arterial Occlusive Thrombotic Response in Rats
by: Amanda B. Matrai, et al.
Published: (2020-03-01) -
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory
by: M. Hardy, et al.
Published: (2020-09-01) -
Développement d’une antithrombine modifiée inactive comme antidote des anticoagulants hépariniques
by: Fazavana, Judicaël
Published: (2012) -
Pediatric Mechanical Circulatory Support: Pathophysiology of Pediatric Hemostasis and Available Options
by: Chiara Giorni, et al.
Published: (2021-09-01)